In contrast to CML, BCR-ABL1 translocation alone is insufficient for malignant transformation, with various complex additional mutations necessary for Ph+ B-ALL development [50]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.